SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1788)6/16/2001 7:30:07 AM
From: Thure Meyer  Read Replies (1) | Respond to of 1837
 
Addition to Russell 3000 is a major liquidity event. All Russell index funds have to adjust positions. That's a lot of buying power



To: vestor who wrote (1788)6/16/2001 9:43:11 PM
From: Thure Meyer  Read Replies (2) | Respond to of 1837
 
Vestor,

Are you still tracking the Cenestin prescription rate?

I did a quick Google search on Cenestin AND 2001 and came up with 34 pages, which indicates some sort of mindshare increase.

On another note; who knows anything about the law suit?

Thure


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News